Comments
Divis Laboratories’ net profit declined 29 percent at ₹348 crore in the second quarter of the current financial year ended September 30, 2023, against ₹493 crore in the corresponding quarter of the previous financial year. The total revenue of the Hyderabad-based company, however, grew 3 per cent at ₹1,909 crore, compared to ₹1,855 crore in the year-ago period.
In the first six months of FY24, the drug-maker’s net profit decreased 41 per cent to ₹704 crore from ₹1,196 crore in the same period previous year. The revenue, too, fell to ₹3,854 crore from ₹4,278 crore. Divis scrip gained 4.65 per cent on the Bombay Stock Exchange on Monday to end at ₹3,505.70.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.